N.I.C.E. Percutaneous radiofrequency ablation of renal cancer

From Kidney Cancer Resource
Jump to: navigation, search

Contents

Overview

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on percutaneous radiofrequency Ablation of renal cancer.

Description

There are few symptoms in the early stages of renal cancer. Typically symptoms develop as the disease progresses. The first symptom is often blood in the urine; pain and flank mass are the other classic symptoms.

The standard treatment for renal cancer is total or partial nephrectomy. However, with the improvement of medical imaging techniques, which have increased the detection of small incidental renal tumours, less invasive procedures have emerged. These include laparoscopic partial nephrectomy, cryoablation, high-intensity ultrasound and radiofrequency ablation.

Percutaneous radiofrequency Ablation may be particularly indicated in patients with small renal tumours (for example less than 4cm diameter), in whom surgery may not be well tolerated, or in patients who refuse surgery.

CT scanning or ultrasound is used for image guidance, and the tumour is destroyed by heating to temperatures exceeding 60°C. In RFA, temperature changes are induced using high-frequency alternating current applied via an electrode or electrodes placed within the tissue to generate ionic agitation.

Arrangements

Other (see guidance)

Topic Area

Cancer Urogenital

Specialty

Clinical oncology

Medical oncology

Urology

Specialist advice has been sought from

Date notified to NICE' 03 June 2003

Guidance Publication Date 22 September 2004

Contact Detail

Project Manager

(for general enquiries or comments) Ben Doak

Technical Lead (for procedure specific enquiries or comments) Sally Wortley

ip@nice.org.uk

Contact Address

Interventional Procedures Programme

National Institute for Health and Clinical Excellence

MidCity Place

71 High Holborn

London

WC1V 6NA

Documents

References

Convert This Page to PDF format

Disclaimer

Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.

E&OE - Errors & Omissions Excepted

As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.

Personal tools
Organisations and People